open access

Vol 28, No 4 (2021)
Letter to the Editor
Submitted: 2020-06-15
Accepted: 2020-07-13
Published online: 2021-02-27
Get Citation

Coronary physiology and percutaneous intervention managed with gadolinium road mapping and intravascular ultrasound in hyperthyroidism

Peter Tajti12, Mohamed Ayoub1, Thomas Nuehrenberg1, Kambis Mashayekhi1
DOI: 10.5603/CJ.a2021.0027
·
Pubmed: 33645627
·
Cardiol J 2021;28(4):642-645.
Affiliations
  1. Department of Interventional Cardiology, Cardiology and Angiology II, University Heart Center Freiburg — Bad Krozingen, Germany
  2. Gottsegen György Hungarian Institute of Cardiology, Budapest, Hungary

open access

Vol 28, No 4 (2021)
Letters to the Editor — Clinical cardiology
Submitted: 2020-06-15
Accepted: 2020-07-13
Published online: 2021-02-27

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Coronary physiology and percutaneous intervention managed with gadolinium road mapping and intravascular ultrasound in hyperthyroidism

Journal

Cardiology Journal

Issue

Vol 28, No 4 (2021)

Article type

Letter to the Editor

Pages

642-645

Published online

2021-02-27

Page views

549

Article views/downloads

441

DOI

10.5603/CJ.a2021.0027

Pubmed

33645627

Bibliographic record

Cardiol J 2021;28(4):642-645.

Authors

Peter Tajti
Mohamed Ayoub
Thomas Nuehrenberg
Kambis Mashayekhi

References (11)
  1. Marraccini P, Bianchi M, Bottoni A, et al. Prevalence of thyroid dysfunction and effect of contrast medium on thyroid metabolism in cardiac patients undergoing coronary angiography. Acta Radiol. 2013; 54(1): 42–47.
  2. Hintze G, Blombach O, Fink H, et al. Risk of iodine-induced thyrotoxicosis after coronary angiography: an investigation in 788 unselected subjects. Eur J Endocrinol. 1999; 140(3): 264–267.
  3. Bonelli N, Rossetto R, Castagno D, et al. Hyperthyroidism in patients with ischaemic heart disease after iodine load induced by coronary angiography: Long-term follow-up and influence of baseline thyroid functional status. Clin Endocrinol (Oxf). 2018; 88(2): 272–278.
  4. Rieger J, Sitter T, Toepfer M, et al. Gadolinium as an alternative contrast agent for diagnostic and interventional angiographic procedures in patients with impaired renal function. Nephrol Dial Transplant. 2002; 17(5): 824–828.
  5. Sayin T, Turhan S, Akyürek O, et al. Gadolinium:nonionic contrast media (1:1) coronary angiography in patients with impaired renal function. Angiology. 2007; 58(5): 561–564.
  6. Juneman E, Saleh L, Thai H, et al. The use of gadolinium in patients with contrast allergy or renal failure requiring coronary angiography, coronary intervention, or vascular procedure. Catheter Cardiovasc Interv. 2011; 78(5): 747–754.
  7. Cubero-Gómez J, Márquez FG, la-Llera LDd, et al. Severe thrombocytopenia induced by iodinated contrast after coronary angiography: The use of gadolinium contrast and intravascular ultrasound as an alternative to guide percutaneous coronary intervention. Rev Port Cardiol. 2017; 36(1): 61.e1–61.e4.
  8. Kälsch H, Kälsch T, Eggebrecht H, et al. Gadolinium-based coronary angiography in patients with contraindication for iodinated x-ray contrast medium: a word of caution. J Interv Cardiol. 2008; 21(2): 167–174.
  9. Ledingham D, Carey P, Junejo S. The dangers of iodine-based contrasts in an elderly patient with thyroid disease. BMJ Case Rep. 2015; 2015.
  10. Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019; 40(2): 87–165.
  11. Ali ZA, Karimi Galougahi K, Nazif T, et al. Imaging- and physiology-guided percutaneous coronary intervention without contrast administration in advanced renal failure: a feasibility, safety, and outcome study. Eur Heart J. 2016; 37(40): 3090–3095.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl